Cluster 1 included allergies, anxiety, depression, chronic obstructive pulmonary disease, fatigue, fever, hypertension, indigestion, insomnia, gastroesophageal reflux disease, hives, swelling, restlessness, and seizures
The emergence of a metabolic drug that incidentally reduces addictive behavior underscores something many clinicians have long suspected: addiction is deeply intertwined with the bodys fundamental regulatory systems appetite, satiety, stress, reward, inflammation including behaviors like binge eating that share overlapping neural pathways
These holistic mental health benefits could greatly increase success rates for substance use disorder populations, beyond simply reducing cravings
GLP-1 , , () clinicians
alone, an estimated 1 in 8 adults nearly 12% of the population have reported using medications such as Wegovy (semaglutide) and Zepbound (tirzepatide)
Your unique genetics determine how well your body makes and uses glutathione and how you respond to diet changes